Bahrain vs Niger: Access to anti-retroviral drugs, male
Bahrain
53.0%
in 2024
Niger
56.0%
in 2024
Bahrain rank
112th
Niger rank
110th
Access to anti-retroviral drugs, male over time
- Bahrain
- Niger
How they compare
Niger currently reports 56.0% against 53.0% in Bahrain, a difference of 3.0%.
That makes Niger's figure about 1.1 times Bahrain's.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 112th and Niger ranks 110th of 141 countries.
Across the 3 decades both report, Bahrain averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Bahrain | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.9% | 3.4% | 6.5% | Bahrain |
| 2010s | 30.1% | 32.7% | 2.6% | Niger |
| 2020s | 52.2% | 56.0% | 3.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bahrain or Niger?
- Niger, at 56.0% against 53.0% in Bahrain as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bahrain and Niger?
- 3.0%, with Niger ahead.
- How many years of comparable data are there for Bahrain and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and Niger rank globally for access to anti-retroviral drugs, male?
- Bahrain ranks 112th and Niger ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.